About
Chief Scientific Officer at Green Park & Golf Ventures since 2017 with a Ph.D. in Neuroscience from UT Southwestern Medical Center. Leads diligence efforts across the firm's healthcare and technology portfolio with published research expertise in molecular biology and cellular mechanisms.
Colleagues at Green Park & Golf Ventures
Carl Soderstrom
Investor at Green Park & Golf Ventures
Claire England
Investment Partner at Green Park & Golf Ventures
Clay Heighten
Investor at Green Park & Golf Ventures
Daniel S. Parsley
Managing Partner, GPG Ventures - Houston at Green Park & Golf Ventures
Dr. Clay Heighten
Founding Member at Green Park & Golf Ventures
Dr. Lauren Tyra
Analyst at Green Park & Golf Ventures
Drew Soderstrom
Investor at Green Park & Golf Ventures
John Leader
Principal, Investment Operations at Green Park & Golf Ventures